Integra Plus (US Pharmaceutical Corporation)
Welcome to the PulseAid listing for the Integra Plus drug offered from US Pharmaceutical Corporation. This Nicotinic Acid [EPC],Nicotinic Acids [Chemical/Ingredient],Vitamin B6 Analog [EPC],Vitamin B 6 [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | US Pharmaceutical Corporation |
NON-PROPRIETARY NAME: | Ferrous Fumarate and Polysacchride Iron Vitamin Mineral Complex Supplement |
SUBSTANCE NAME: | FERROUS FUMARATE; FERROUS ASPARTO GLYCINATE; FOLIC ACID; ASCORBIC ACID; NIACIN; THIAMINE MONONITRATE; RIBOFLAVIN; CALCIUM PANTOTHENATE; PYRIDOXINE HYDROCHLORIDE; BIOTIN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Nicotinic Acid [EPC],Nicotinic Acids [Chemical/Ingredient],Vitamin B6 Analog [EPC],Vitamin B 6 [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
START MARKETING DATE: | 2009-04-27 |
END MARKETING DATE: | 0000-00-00 |
Integra Plus HUMAN PRESCRIPTION DRUG Details:
Item Description | Integra Plus from US Pharmaceutical Corporation |
LABELER NAME: | US Pharmaceutical Corporation |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 191.2; 135.9; 1; 210; 20; 5; 5; 7; 25; 300(mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; ug/1) |
START MARKETING DATE: | 2009-04-27 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 52747-712_d8d20e53-d247-46a1-b572-8b541e453051 |
PRODUCT NDC: | 52747-712 |
APPLICATION NUMBER: | |
Other FERROUS FUMARATE; FERROUS ASPARTO GLYCINATE; FOLIC ACID; ASCORBIC ACID; NIACIN; THIAMINE MONONITRATE; RIBOFLAVIN; CALCIUM PANTOTHENATE; PYRIDOXINE HYDROCHLORIDE; BIOTIN Pharmaceutical Manufacturers / Labelers: